ArticleAnnals of translational medicine2021
Radiomic signatures based on multiparametric MR images for predicting Ki-67 index expression in medulloblastoma.
Article in Annals of translational medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed.
- Preoperative multiparameter MRI-based prediction of Ki-67 expression in primary central nervous system lymphoma.Precision radiation oncology · 2025Article
- The value of multiparametric MRI radiomics and machine learning in predicting preoperative Ki-67 expression level in breast cancer.BMC medical imaging · 2025Article
- Combining clinical characteristics with CT radiomics to predict Ki67 expression level of small renal mass based on artificial intelligence algorithms.Frontiers in oncology · 2025Article
- Radiomic- and dosiomic-based clustering development for radio-induced neurotoxicity in pediatric medulloblastoma.Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery · 2024Article
- The current state of MRI-based radiomics in pituitary adenoma: promising but challenging.Frontiers in endocrinology · 2024Review
- MRI Radiomics-Based Machine Learning Models for Ki67 Expression and Gleason Grade Group Prediction in Prostate Cancer.Cancers · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundMedulloblastoma (MB) is a common central nervous system tumor in children with extensive heterogeneity and different prognoses. This study aimed to classify the Ki-67 index in MB with radiomic characteristics based on multi-parametric magnetic resonance imaging to guide treatment and assess the prognosis of patients.
methodsThree sequences of T1W, CE-T1W, and T2W were used as test data. Two experienced radiologists manually segmented the tumors according to T2W images from 90 patients. The patients were divided into training and test sets at a ratio of 7:3, and 833 dimensional image features were extracted for each patient. Five models were trained using the feature set selected in three ways. Finally, the area under the curve (AUC) and accuracy (ACC) were used on the test set to evaluate the performance of the different models.
resultsA random forest (RF) model combining three sequence features achieved the best performance (ACC: 0.771, 95% CI: 0.727 to 0.816; AUC: 0.697, 95% CI: 0.614 to 0.78). The voting model that combined a RF and a support vector machine (SVM) had higher performance than the other models (ACC: 0.796, 95% CI: 0.76 to 0.833; AUC: 0.689, 95% CI: 0.615 to 0.763). The best prediction model that used only one sequence feature was voting in the T2W sequence (ACC: 0.736, 95% CI: 0.705 to 0.766; AUC: 0.636, 95% CI: 0.585 to 0.688). The ensemble model was better than the single training model, and a multi-sequence combination was better than a single sequence prediction. The multiple feature selection methods were better than a combination of the two methods.
conclusionsA model obtained by machine learning could help doctors predict the Ki-67 values of patients more efficiently to make targeted judgments for subsequent treatments.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.